搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Phaeosphaeria nodorum Lysophospholipase NTE1 (NTE1), partial CSB-YP611699EUG
CSB-EP611699EUG
CSB-BP611699EUG
CSB-MP611699EUG
CSB-EP611699EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Dicer-like protein 2 (DCL2), partial CSB-YP611700EUG
CSB-EP611700EUG
CSB-BP611700EUG
CSB-MP611700EUG
CSB-EP611700EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Pre-mRNA-processing ATP-dependent RNA helicase PRP5 (PRP5), partial CSB-YP611701EUG
CSB-EP611701EUG
CSB-BP611701EUG
CSB-MP611701EUG
CSB-EP611701EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum ATP-dependent rRNA helicase SPB4 (SPB4), partial CSB-YP611702EUG
CSB-EP611702EUG
CSB-BP611702EUG
CSB-MP611702EUG
CSB-EP611702EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum ATP-dependent RNA helicase HAS1 (HAS1), partial CSB-YP611703EUG
CSB-EP611703EUG
CSB-BP611703EUG
CSB-MP611703EUG
CSB-EP611703EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Fe-S cluster assembly protein DRE2 (DRE2) CSB-YP611704EUG
CSB-EP611704EUG
CSB-BP611704EUG
CSB-MP611704EUG
CSB-EP611704EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Probable lysosomal cobalamin transporter (SNOG_04623), partial CSB-YP611705EUG
CSB-EP611705EUG
CSB-BP611705EUG
CSB-MP611705EUG
CSB-EP611705EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum tRNA (guanine (37)-N1)-methyltransferase (TRM5) CSB-YP611706EUG
CSB-EP611706EUG
CSB-BP611706EUG
CSB-MP611706EUG
CSB-EP611706EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Autophagy protein 5 (ATG5) CSB-YP611707EUG
CSB-EP611707EUG
CSB-BP611707EUG
CSB-MP611707EUG
CSB-EP611707EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum ATP-dependent RNA helicase DBP9 (DBP9), partial CSB-YP611708EUG
CSB-EP611708EUG
CSB-BP611708EUG
CSB-MP611708EUG
CSB-EP611708EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Flap endonuclease 1 (FEN1) CSB-YP611709EUG
CSB-EP611709EUG
CSB-BP611709EUG
CSB-MP611709EUG
CSB-EP611709EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum U3 small nucleolar RNA-associated protein 10 (UTP10), partial CSB-YP611710EUG
CSB-EP611710EUG
CSB-BP611710EUG
CSB-MP611710EUG
CSB-EP611710EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Protein DML1 (DML1), partial CSB-YP611711EUG
CSB-EP611711EUG
CSB-BP611711EUG
CSB-MP611711EUG
CSB-EP611711EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Histone H2A.Z-specific chaperone CHZ1 (CHZ1) CSB-YP611712EUG
CSB-EP611712EUG
CSB-BP611712EUG
CSB-MP611712EUG
CSB-EP611712EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Hsp70 nucleotide exchange factor FES1 (FES1) CSB-YP611713EUG
CSB-EP611713EUG
CSB-BP611713EUG
CSB-MP611713EUG
CSB-EP611713EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeosphaeria nodorum Structure-specific endonuclease subunit SLX4 (SLX4), partial CSB-YP611714EUG
CSB-EP611714EUG
CSB-BP611714EUG
CSB-MP611714EUG
CSB-EP611714EUG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Protein FAM167A (FAM167A) CSB-YP611715BO
CSB-EP611715BO
CSB-BP611715BO
CSB-MP611715BO
CSB-EP611715BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Transcription factor FER-LIKE IRON DEFICIENCY-INDUCED TRANSCRIPTION FACTOR (FIT) CSB-YP611716DOA
CSB-EP611716DOA
CSB-BP611716DOA
CSB-MP611716DOA
CSB-EP611716DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Negative elongation factor E (RDBP) CSB-YP611717BO
CSB-EP611717BO
CSB-BP611717BO
CSB-MP611717BO
CSB-EP611717BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Nuclear receptor subfamily 4 group A member 1 (NR4A1), partial CSB-YP611718BO
CSB-EP611718BO
CSB-BP611718BO
CSB-MP611718BO
CSB-EP611718BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>